Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Lepore

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Experimental Medicine|June 18, 2014
A novel self-lipid antigen targets human T cells against CD1c(+) leukemiasMarco Lepore, Claudia de Lalla, S Ramanjaneyulu Gundimeda, et al.
Science Immunology|May 10, 2024
Nucleobase adducts bind MR1 and stimulate MR1-restricted T cellsAlessandro Vacchini, Andrew Chancellor, Qinmei Yang, et al.
The Journal of Experimental Medicine|June 29, 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responsesAndrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, et al.
The Journal of Clinical Investigation|April 21, 2020
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLAChristopher J Holland, Rory M Crean, Johanne M Pentier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2024
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosisRachel L Paterson, Marco P La Manna, Victoria Arena De Souza, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Experimental Medicine|June 18, 2014
A novel self-lipid antigen targets human T cells against CD1c(+) leukemiasMarco Lepore, Claudia de Lalla, S Ramanjaneyulu Gundimeda, et al.
Science Immunology|May 10, 2024
Nucleobase adducts bind MR1 and stimulate MR1-restricted T cellsAlessandro Vacchini, Andrew Chancellor, Qinmei Yang, et al.
The Journal of Experimental Medicine|June 29, 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responsesAndrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, et al.
The Journal of Clinical Investigation|April 21, 2020
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLAChristopher J Holland, Rory M Crean, Johanne M Pentier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2024
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosisRachel L Paterson, Marco P La Manna, Victoria Arena De Souza, et al.
Pageof 3